Protective Role of the Toll-Like Receptor 5 Agonist KMRC011 against Murine Colitis Induced by Citrobacter rodentium and Dextran Sulfate Sodium

por Kim, Jun-Young, Seo, Sun-Min, Kim, Han-Woong, Lee, Woo-Jong, Choi, Yang-Kyu
Publicado 2023

A first‐in‐human study of KMRC011, a potential treatment for acute radiation syndrome, to explore tolerability, pharmacokinetics, and pharmacodynamics

por Yang, Eunsol, Choi, Hyejung, Park, Jin‐Sol, Noh, Young‐Woock, Choi, Chi‐Min, Lee, Woo‐Jong, Ko, Jae‐Wook, Kim, Jungryul
Publicado 2021

IgLON5 Regulates the Adhesion and Differentiation of Myoblasts

por Lim, Jeong Ho, Beg, Mirza Masroor Ali, Ahmad, Khurshid, Shaikh, Sibhghatulla, Ahmad, Syed Sayeed, Chun, Hee Jin, Choi, Dukhwan, Lee, Woo-Jong, Jin, Jun-O, Kim, Jihoe, Jan, Arif Tasleem, Lee, Eun Ju, Choi, Inho
Publicado 2021

Radioprotective effect of newly synthesized toll-like receptor 5 agonist, KMRC011, in mice exposed to total-body irradiation

por Kim, Jun-Young, Park, Jong-Hyung, Seo, Sun-Min, Park, Jin-Il, Jeon, Hee-Yeon, Lee, Han-Kyul, Yoo, Ran-Ji, Lee, Yong-Jin, Woo, Sang-Keun, Lee, Woo-Jong, Choi, Chi-Min, Choi, Yang-Kyu
Publicado 2019